久之洋(300516.SZ)中標2.4億元某型紅外設備項目
格隆匯4月22日丨久之洋(300516.SZ)公佈,公司於近日收到招標方發來的中標通知書,確認公司為某型紅外設備中標單位,中標金額約2.4億元,因部分信息涉及國家祕密,公司根據軍工企業對外信息披露相關規定,豁免披露銷售對象的具體信息。
此次中標項目與2020年1月份中標項目的落地,進一步鞏固了公司在軍用紅外領域的優勢地位,為公司後續技術提升與穩健發展打下堅實基礎。
該中標項目正式簽訂合同且順利實施後,預計將對公司後續經營業績產生積極影響。公司與招標單位之間不存在關聯關係,上述項目中標不會對公司業務的獨立性產生影響,公司主要業務不會因履行合同而對交易對方形成依賴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.